Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T15:11:42.603Z Has data issue: false hasContentIssue false
  • English
  • Français

The 21-item Depression Anxiety Stress Scales as a valid routine clinical outcome measure in the private in-patient setting

Published online by Cambridge University Press:  24 June 2014

F Ng ,
M Berk ,
S Campbell ,
T Callaly ,
S Dodd  and
T Trauer
F Ng
Affiliation:
Barwon Health The University of Melbourne, Melbourne, Australia
M Berk
Affiliation:
The University of Melbourne, Melbourne, Australia
S Campbell
Affiliation:
Healthscope, Melbourne, Australia
T Callaly
Affiliation:
Barwon Health
S Dodd
Affiliation:
The University of Melbourne, Melbourne, Australia
T Trauer
Affiliation:
The University of Melbourne, Melbourne, Australia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstracts from ‘Brainwaves’— The Australasian Society for Psychiatric Research Annual Meeting 2006, 6–8 December, Sydney, Australia
Information
Acta Neuropsychiatrica , Volume 18 , Issue 6 , December 2006 , pp. 300
Copyright
Copyright © 2006 Blackwell Munksgaard

Background:

The self-reported 21-item Depression Anxiety Stress Scales (DASS-21) measure and differentiate negative affective states, which is especially meaningful in the acute psychiatric treatment setting. This study aimed to test the validity of DASS-21 as a routine clinical outcome measure in the private psychiatric in-patient setting.

Methods:

The sample consisted of all admissions to a private psychiatric hospital from January 2004 to December 2005. Scores of four routine measures administered at admission and discharge were retrospectively collected. These measures were the clinician-rated Clinical Global Impression Scale (CGI) and Health of the Nation Outcome Scales in its adult or older persons format (HoNOS or HoNOS65+), and the self-reported Mental Health Questionnaire (MHQ-14) and DASS-21. The four measures were compared using correlation statistics, and differences in measure scores from admission to discharge were analyzed by t test.

Results:

Of 786 total admissions, there were 337, 328 and 347 fully completed (ie paired admission and discharge) data sets for the DASS-21 depression, anxiety and stress subscales, respectively. All subscales showed significant reductions in mean scores, in the order of 50%, at discharge compared with baseline (P < 0.001). All subscales were correlated with the MHQ-14 subscales (P < 0.0001). They also related to partially collapsed CGI categories (P = 0.006), except for the baseline stress subscale. The total DASS-21 correlated with the total HoNOS scores (r = 0.31, P < 0.0001).

Conclusion:

The results support the validity of DASS-21 as a routine clinical outcome measure in the private in-patient setting.